Evaluation of Vascular Event Risk while on Long-term Anti-retroviral Suppressive Therapy [EVERLAST]: Protocol for a prospective observational study

Evaluation of Vascular Event Risk while on Long-term Anti-retroviral Suppressive Therapy [EVERLAST]: Protocol for a prospective observational study

Background & objective: Cardiovascular disease (CVD) risk among the HIV population is high due to a combination of accelerated atherosclerosis from the pro-inflammatory milieu created by chronic HIV infection and the potentially adverse metabolic side effects from cART (combination antiretrovira...

Full description

Bibliographic Details
Main Authors: Fred Stephen Sarfo, Michelle Nichols, Mulugeta Gebregziabher, Raelle Tagge, Shadrack Osei Asibey, Carolyn Jenkins, Bruce Ovbiagele
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:eNeurologicalSci
Online Access:http://www.sciencedirect.com/science/article/pii/S2405650219300139

Internet

http://www.sciencedirect.com/science/article/pii/S2405650219300139

Similar Items